Literature DB >> 17551355

Prevalence and correlates of cannabis use in developed and developing countries.

Wayne Hall1, Louisa Degenhardt.   

Abstract

PURPOSE OF REVIEW: The aim of this article is to review recent research on the prevalence, antecedents and correlates of cannabis use in young adults in developed and developing countries. RECENT
FINDINGS: Cannabis is the most widely used illicit drug globally and its use appears to be increasing in developed and developing countries. In developed countries rebelliousness, antisocial behaviour, poor school performance, and affiliation with drug-using peers are risk factors for early and regular cannabis use. Similar antecedents are now being reported in developing countries. Dependence is an underappreciated risk of cannabis that affects one in six to seven adolescents who use cannabis in developed countries. Adolescent cannabis dependence is correlated with an increased risk of using other illicit drugs, symptoms of depression, and symptoms of psychosis. The plausibility of cannabis playing a contributory causal role has increased for symptoms of psychosis in longitudinal studies but remains contentious. In the case of other illicit drug use and mood disorders common causal explanations remain difficult to exclude.
SUMMARY: Early and regular cannabis use in adolescence predicts an increased risk of cannabis dependence which in turn predicts an increased risk of using other illicit drugs, and reporting symptoms of mood and psychotic disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17551355     DOI: 10.1097/YCO.0b013e32812144cc

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  51 in total

Review 1.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins.

Authors:  Ragnar Nesvåg; Ted Reichborn-Kjennerud; Nathan A Gillespie; Gun Peggy Knudsen; Jørgen G Bramness; Kenneth S Kendler; Eivind Ystrom
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

3.  Do adolescent ecstasy users have different attitudes towards drugs when compared to marijuana users?

Authors:  Silvia S Martins; Carla L Storr; Pierre K Alexandre; Howard D Chilcoat
Journal:  Drug Alcohol Depend       Date:  2007-12-18       Impact factor: 4.492

Review 4.  The endocannabinoid system as a target for the treatment of cannabis dependence.

Authors:  Jason R Clapper; Regina A Mangieri; Daniele Piomelli
Journal:  Neuropharmacology       Date:  2008-07-19       Impact factor: 5.250

5.  Cannabis, a complex plant: different compounds and different effects on individuals.

Authors:  Zerrin Atakan
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

6.  Exploring pathways to substance use: A longitudinal examination of adolescent sport involvement, aggression, and peer substance use.

Authors:  Julie V Cristello; Elisa M Trucco; Robert A Zucker
Journal:  Addict Behav       Date:  2020-01-14       Impact factor: 3.913

7.  Marijuana use from adolescence to adulthood: developmental trajectories and their outcomes.

Authors:  Judith S Brook; Chenshu Zhang; Carl G Leukefeld; David W Brook
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-05-11       Impact factor: 4.328

8.  Psychobiological responses to unpleasant emotions in cannabis users.

Authors:  Lorenzo Somaini; Matteo Manfredini; Mario Amore; Amir Zaimovic; Maria Augusta Raggi; Claudio Leonardi; Maria Lidia Gerra; Claudia Donnini; Gilberto Gerra
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-07-20       Impact factor: 5.270

9.  Geographical clustering of cannabis use: results from the New Zealand Mental Health Survey 2003-2004.

Authors:  J Elisabeth Wells; Louisa Degenhardt; Kipling M Bohnert; James C Anthony; Kate M Scott
Journal:  Drug Alcohol Depend       Date:  2008-11-06       Impact factor: 4.492

10.  Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

Authors:  Eugene W Schwilke; David M Schwope; Erin L Karschner; Ross H Lowe; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.